Abbott Laboratories
ABT
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irā¦ read more
Healthcare
Medical Devices
45 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$126.36
Price+1.13%
$1.41
1Y
Price
Market Cap
$219.937b
Large
Price/Earnings 3y Avg5y Avg
15.9x
Premium
Premium
Financials Overview
Key metrics over the past few years+19.6%
EBITDA Margin+14.5%
Net Profit Margin+13.6%
Free Cash Flow MarginRevenue
$43.843b
+4.5%
1y CAGR+0.3%
3y CAGR+0.6%
5y CAGREarnings
$13.977b
+4.3%
1y CAGR+40.3%
3y CAGR+29.8%
5y CAGREPS
$7.98
+4.5%
1y CAGR+40.6%
3y CAGR+30.2%
5y CAGRBook Value
$50.829b
$83.999b
Assets$33.170b
Liabilities$13.437b
DebtDebt to Assets
16.0%
1.2x
Debt to EBITDAFree Cash Flow
$6.775b
+6.7%
1y CAGR-1.0%
3y CAGR-3.2%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company